Skip to main content

Table 1 Baseline characteristics in the original cohort

From: Impact of initial ventilation strategies on in-hospital mortality in sepsis patients: insights from the MIMIC-IV database

Variables

Total (n = 19796)

IMV (n = 9723)

NIV (n = 10073)

Statistic

P

Age

66.81 ± 16.05

65.01 ± 15.69

68.54 ± 16.20

t=-15.59

< 0.001

Gender, n(%)

   

χ²=118.68

< 0.001

 F

8204 (41.44)

3652 (37.56)

4552 (45.19)

  

 M

11,592 (58.56)

6071 (62.44)

5521 (54.81)

  

Race, n(%)

   

χ²=36.34

< 0.001

Black

1485 (8.56)

638 (7.74)

847 (9.31)

  

Other

2471 (14.25)

1294 (15.70)

1177 (12.94)

  

White

13,384 (77.19)

6312 (76.56)

7072 (77.75)

  

Weigh

83.69 ± 23.94

85.61 ± 23.69

81.82 ± 24.03

t = 11.12

< 0.001

Laboratory Tests

 WBC (× 109/L)

13.33 ± 10.24

13.60 ± 10.78

13.06 ± 9.68

t = 3.67

< 0.001

 Platelet (× 1012/L)

196.37 ± 104.20

188.55 ± 95.76

203.96 ± 111.27

t=-10.42

< 0.001

 Hemoglobin (× 109/L)

10.52 ± 1.89

10.57 ± 1.82

10.48 ± 1.95

t = 3.19

0.001

 PH

7.37 ± 0.07

7.36 ± 0.07

7.37 ± 0.07

t=-8.60

< 0.001

 pCO2 (mmHg)

41.74 ± 9.34

41.56 ± 8.35

41.98 ± 10.50

t=-2.71

0.007

 pO2 (mmHg)

151.20 ± 83.55

174.63 ± 81.31

120.14 ± 76.02

t = 43.99

< 0.001

 PO2/FiO2

363.79 ± 256.12

411.82 ± 259.32

275.31 ± 224.70

t = 33.24

< 0.001

 Lactate l (mmol/L)

2.32 ± 1.78

2.48 ± 2.01

2.14 ± 1.44

t = 12.52

< 0.001

 Ureanitrogen (mg/dL)

27.45 ± 21.37

25.06 ± 19.80

29.76 ± 22.55

t=-15.55

< 0.001

 Creatinine(mg/dL)

1.46 ± 1.42

1.34 ± 1.22

1.58 ± 1.57

t=-11.85

< 0.001

 eGFR

74.47 ± 46.04

79.33 ± 47.10

69.77 ± 44.49

t = 14.65

< 0.001

Vital Signs

 MAP (mmHg)

80.47 ± 612.21

85.31 ± 908.87

76.47 ± 51.70

t = 0.95

0.344

 Respiratory rate (bpm)

24.19 ± 644.61

28.30 ± 919.90

20.21 ± 4.29

t = 0.88

0.378

 Spo2(%)

99.82 ± 301.94

99.26 ± 164.73

100.35 ± 391.12

t=-0.25

0.799

 Temperature (°C)

36.84 ± 1.89

36.83 ± 2.59

36.85 ± 1.04

t=-0.87

0.386

Disease Severity Score

 GCS

15.00 (13.00, 15.00)

15.00 (14.00, 15.00)

14.00 (13.00, 15.00)

Z=-14.84

< 0.001

 SAPS II score

38.00 (31.00, 48.00)

40.00 (32.00, 51.00)

37.00 (29.00, 46.00)

Z=-20.32

< 0.001

 SOFA score

5.00 (3.00, 8.00)

6.00 (4.00, 9.00)

5.00 (3.00, 7.00)

Z=-24.01

< 0.001

Comorbidities

 HF

   

χ²=162.54

< 0.001

  No

14,127 (71.36)

7344 (75.53)

6783 (67.34)

  

  Yes

5669 (28.64)

2379 (24.47)

3290 (32.66)

  

 MT

   

χ²=68.55

< 0.001

  No

16,601 (83.86)

8368 (86.06)

8233 (81.73)

  

  Yes

3195 (16.14)

1355 (13.94)

1840 (18.27)

  

 CKD

   

χ²=104.12

< 0.001

  No

16,277 (82.22)

8269 (85.05)

8008 (79.50)

  

  Yes

3519 (17.78)

1454 (14.95)

2065 (20.50)

  

 AKF

   

χ²=230.45

< 0.001

  No

12,331 (62.29)

6574 (67.61)

5757 (57.15)

  

  Yes

7465 (37.71)

3149 (32.39)

4316 (42.85)

  

 Stroke

   

χ²=3.33

0.068

  No

17,994 (90.90)

8801 (90.52)

9193 (91.26)

  

  Yes

1802 (9.10)

922 (9.48)

880 (8.74)

  

 COPD

   

χ²=43.60

< 0.001

  No

18,289 (92.39)

9106 (93.65)

9183 (91.16)

  

  Yes

1507 (7.61)

617 (6.35)

890 (8.84)

  

 Respiratory failure, n (%)

   

χ²=144.99

< 0.001

  No

12,325 (62.26)

5643 (58.04)

6682 (66.34)

  

  Yes

7471 (37.74)

4080 (41.96)

3391 (33.66)

  

 Hypoxemia, n (%)

   

χ²=18.38

< 0.001

  No

17,458 (88.19)

8672 (89.19)

8786 (87.22)

  

  Yes

2338 (11.81)

1051 (10.81)

1287 (12.78)

  

 Hypercapnia, n (%)

   

χ²=0.87

0.352

  No

19,280 (97.39)

9480 (97.50)

9800 (97.29)

  

  Yes

516 (2.61)

243 (2.50)

273 (2.71)

  

 Lactic acidosis, n (%)

   

χ²=0.83

0.361

  No

15,986 (80.75)

7877 (81.01)

8109 (80.50)

  

  Yes

3810 (19.25)

1846 (18.99)

1964 (19.50)

  
  1. WBC white blood cell, MAP mean arterial pressure, PO2 partial pressure of oxygen, PCO2 partial pressure of carbon dioxide, FiO2 Fraction of Inspired Oxygen, GCS Glasgow coma score, SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ Failure Assessment, HF heart failure, MT Malignant tumor, COPD chronic obstructive pulmonary disease, CKD chronic kidney disease, AKF acute kidney failure